Addition of iron to erythropoiesis-stimulating agents in cancer patients: a meta-analysis of randomized trials

被引:0
作者
Fausto Petrelli
Karen Borgonovo
Mary Cabiddu
Veronica Lonati
Sandro Barni
机构
[1] Oncology Unit,
[2] Azienda Ospedaliera Treviglio-Caravaggio,undefined
来源
Journal of Cancer Research and Clinical Oncology | 2012年 / 138卷
关键词
Erythropoiesis-stimulating agents; Parenteral iron; Oral iron; Anemia; Hematopoietic response; Solid tumors;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:179 / 187
页数:8
相关论文
共 54 条
[11]  
Kris M(2007)Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy The Oncol 12 231-2034
[12]  
Wade J(2003)Darbepoetin alfa administered every 3 weeks alleviates anaemia in patients with solid tumours receiving chemotherapy: results of a double-blind, placebo-controlled, randomised study Eur J Cancer 39 2026-2874
[13]  
Gabrilove JL(2001)Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial J Clin Oncol 19 2865-902
[14]  
Cleeland CS(2010)Efficacy and safety of oral lactoferrin supplementation in combination with rHuEPO-beta for the treatment of anemia in advanced cancer patients undergoing chemotherapy: open-label, randomized controlled study The Oncol 15 894-1625
[15]  
Livingston RB(2008)Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha J Clin Oncol 26 1619-5010
[16]  
Ganz T(2010)American Society of Clinical Oncology; American Society of Hematology. American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer J Clin Oncol 28 4996-105
[17]  
Glaspy J(2011)Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia J Clin Oncol 29 97-138
[18]  
Bukowski R(2001)Assessment of hematologic effects and fatigue in cancer patients with chemotherapy-induced anemia given darbepoetin alfa every two weeks J Support Oncol 1 131-1220
[19]  
Steinberg D(2002)Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy J Natl Cancer Inst 94 1211-undefined
[20]  
Hedenus M(undefined)undefined undefined undefined undefined-undefined